Table 1 Descriptions of the demographic and clinical features of tetanus patients
From: Urinary catecholamine excretion, cardiovascular variability, and outcomes in tetanus
Characteristic | N | Median [Q1–Q3], mean (SD) or count (%) |
|---|---|---|
Age (years) | 263 | 49 (14) |
Male sex | 263 | 222 (84.4%) |
BMI (kg/m2) | 263 | 21.33 [19.82, 23.16] |
Coexisting comorbidities | 263 | 121 (46.0%) |
Duration of illness (days) | 263 | 3 [2, 5] |
Incubation period (days) | 202 | 9 [6, 14] |
Period of onset (h) | 230 | 48 [24, 72] |
Ablett Score* on admission | 263 | |
I | 47 (17.9%) | |
II | 196 (74.5%) | |
III | 20 (7.6%) | |
APACHE II Score | 263 | 3 [2, 7] |
SOFA Score | 263 | |
0 | 228 (86.7%) | |
≥ 1 | 35 (13.3%) | |
Tetanus Severity Score** | 263 | 0 [− 3, 4] |
Outcome | 263 | |
In-hospital death or palliative discharge | 2 (0.8%) | |
Transfer to other facility | 6 (2.3%) | |
Alive hospital discharge | 255 (97.0%) | |
ICU length of stay (days) | 261 | 14 [8, 22] |
Mechanical ventilation during hospitalization | 263 | 123 (46.8%) |
Autonomic nervous system disturbance (ANSD) | 263 | 49 (18.6%) |